Surrogacy Fraud Unveiled in Telangana

The article reports on a disturbing case of illegal surrogacy and baby-selling in Secunderabad, Telangana, involving Universal Srushti Fertility Centre. The couple, Sonam Singh and Akshay, traveled from Rajasthan for an IVF procedure but were misled into surrogacy that cost ₹30 lakh, instead of the IVF procedure that could range between ₹2 lakh and ₹6 lakh. After handing over payments, they discovered that the baby they received was not biologically related to them. They confronted the clinic when DNA tests confirmed their fears, only to find that the doctor, Pachipala Namratha, had vanished.

Key Points:

• Medical Tourism Hotspot: Secunderabad, along with Hyderabad, is a significant hub for medical tourism in India, particularly for fertility treatments.

• Surrogacy Misrepresentation: The couple was promised an 85% success rate and convinced to opt for surrogacy, which was heavily overpriced compared to IVF.

• Legal Violations: The doctor was charged under various sections of the Bharatiya Nyaya Sanhita Act, 2023, (criminal conspiracy, breach of trust, forgery) and the Surrogacy (Regulation) Act, 2021, which prohibits commercial surrogacy.

• Similar Cases Uncovered: Investigations revealed that at least 15 couples had been defrauded, with falsified documents issued by the clinic.

• Human Exploitation: Vulnerable women were preyed upon and offered money to carry pregnancies for surrogacy, often with no payments received afterward.

• Tragic Incident: A surrogate’s death during an escape from an alleged sexual assault highlighted the dangerous circumstances surrounding surrogacy arrangements.

• Child Welfare: Babies involved in these scams have been taken into child care facilities under the Women and Child Welfare Department.

• Black Market for Donors: Another raid uncovered a facility named Indian Sperm Tech, operating unlicensed, where sperm and egg donors were being sought and paid inadequately.

• Legal Framework: The Surrogacy (Regulation) Act, 2021, allows only altruistic surrogacy in India, forbidding any commercial transaction.

• Regulatory Measures: Stringent systems are being put into place to ensure the ethical conduct of fertility clinics under the ART Regulation Act, 2021, emphasizing proper documentation, donor screening, and the legality of procedures.

• Tech-Driven Safeguards: Clinics are encouraged to adopt the RI Witness system for tracking bio-samples, enhancing accountability amid rising cases of unethical practices.

• Historical Context: Namratha had a previous surrogacy scandal in 2016 and faced disciplinary action from the Telangana Medical Council, which highlights ongoing issues in the surrogacy sector.

This case sheds light on the need for increased scrutiny of fertility services in India, reinforcing the importance of regulatory frameworks to protect vulnerable populations and ensure ethical medical practices in surrogacy and reproductive technology. The efficacy of new regulations is crucial to prevent the recurrence of such exploitation within the surrogacy landscape.